VIAF

Virtual International Authority File

Search

Leader     00000nz a2200037n 45 0
001     WKP|Q63922456  (VIAF cluster)  (Authority/Source Record)
003     WKP
005     20241120235919.0
008     241120nneanz||abbn n and d
035 ‎‡a  (WKP)Q63922456‏
024 ‎‡a  0000-0001-7567-8519‏ ‎‡2  orcid‏
035 ‎‡a  (OCoLC)Q63922456‏
100 0 ‎‡a  Marc D Jansen‏ ‎‡c  researcher‏ ‎‡9  en‏
375 ‎‡a  1‏ ‎‡2  iso5218‏
400 0 ‎‡a  Marc D Jansen‏ ‎‡c  wetenschapper‏ ‎‡9  nl‏
670 ‎‡a  Author's A novel PCR-based method for direct Fc gamma receptor IIIa‏
670 ‎‡a  Author's A novel PCR-based method for direct Fc gamma receptor IIIa (CD16) allotyping‏
670 ‎‡a  Author's Association of the Fc gamma receptor IIA-R/R131 genotype with myasthenia gravis in Dutch patients.‏
670 ‎‡a  Author's Autoantibody pathogenicity in a multifocal motor neuropathy induced pluripotent stem cell-derived model.‏
670 ‎‡a  Author's Characterization of Dutch Staphylococcus aureus from bovine mastitis using a Multiple Locus Variable Number Tandem Repeat Analysis‏
670 ‎‡a  Author's Complement activity is associated with disease severity in multifocal motor neuropathy‏
670 ‎‡a  Author's Evidence for non-random distribution of Fcgamma receptor genotype combinations‏
670 ‎‡a  Author's Fcgamma receptor gene polymorphisms in Japanese patients with systemic lupus erythematosus: contribution of FCGR2B to genetic susceptibility‏
670 ‎‡a  Author's Fcgamma receptor polymorphisms in systemic lupus erythematosus: association with disease and in vivo clearance of immune complexes‏
670 ‎‡a  Author's Ganglioside-specific IgG and IgA recruit leukocyte effector functions in Guillain-Barré syndrome‏
670 ‎‡a  Author's IVIg inhibits classical pathway activity and anti-GM1 IgM-mediated complement deposition in MMN‏
670 ‎‡a  Author's Leukocyte and complement activation by GM1-specific antibodies is associated with acute motor axonal neuropathy in rabbits‏
670 ‎‡a  Author's No association of Fc gamma RIIa, Fc gamma RIIIa and Fc gamma RIIIb polymorphisms with MS.‏
670 ‎‡a  Author's Pathogenicity of anti-ganglioside antibodies in the Guillain-Barré syndrome.‏
670 ‎‡a  Author's Quantification of SMN protein in leucocytes from spinal muscular atrophy patients: effects of treatment with valproic acid‏
670 ‎‡a  Author's Relevance of Fcgamma receptor and interleukin-10 polymorphisms for meningococcal disease‏
670 ‎‡a  Author's SCCmec typing in methicillin-resistant Staphylococcus aureus strains of animal origin.‏
670 ‎‡a  Author's Severity of Guillain-Barré syndrome is associated with Fc gamma Receptor III polymorphisms‏
670 ‎‡a  Author's Streptococcus pneumoniae in saliva of Dutch primary school children‏
670 ‎‡a  Author's The R-H polymorphism of FCgamma receptor IIa as a risk factor for systemic lupus erythematosus is independent of single-nucleotide polymorphisms in the interleukin-10 gene promoter‏
670 ‎‡a  Author's Transmission of methicillin-resistant Staphylococcus aureus strains between different kinds of pig farms‏
909 ‎‡a  (orcid) 0000000175678519‏ ‎‡9  1‏
919 ‎‡a  novelpcrbasedmethodfordirectfcgammareceptoriiiacd16allotyping‏ ‎‡A  A novel PCR-based method for direct Fc gamma receptor IIIa (CD16) allotyping‏ ‎‡9  1‏
919 ‎‡a  novelpcrbasedmethodfordirectfcgammareceptoriiia‏ ‎‡A  A novel PCR-based method for direct Fc gamma receptor IIIa‏ ‎‡9  1‏
919 ‎‡a  associationofthefcgammareceptoriiarr131genotypewithmyastheniagravisindutchpatients‏ ‎‡A  Association of the Fc gamma receptor IIA-R/R131 genotype with myasthenia gravis in Dutch patients.‏ ‎‡9  1‏
919 ‎‡a  autoantibodypathogenicityinamultifocalmotorneuropathyinducedpluripotentstemcellderivedmodel‏ ‎‡A  Autoantibody pathogenicity in a multifocal motor neuropathy induced pluripotent stem cell-derived model.‏ ‎‡9  1‏
919 ‎‡a  characterizationofdutchstaphylococcusaureusfrombovinemastitisusingamultiplelocusvariablenumbertandemrepeatanalysis‏ ‎‡A  Characterization of Dutch Staphylococcus aureus from bovine mastitis using a Multiple Locus Variable Number Tandem Repeat Analysis‏ ‎‡9  1‏
919 ‎‡a  complementactivityisassociatedwithdiseaseseverityinmultifocalmotorneuropathy‏ ‎‡A  Complement activity is associated with disease severity in multifocal motor neuropathy‏ ‎‡9  1‏
919 ‎‡a  evidencefornonrandomdistributionoffcgammareceptorgenotypecombinations‏ ‎‡A  Evidence for non-random distribution of Fcgamma receptor genotype combinations‏ ‎‡9  1‏
919 ‎‡a  fcgammareceptorgenepolymorphismsinjapanesepatientswithsystemiclupuserythematosuscontributionoffcgr2btogeneticsusceptibility‏ ‎‡A  Fcgamma receptor gene polymorphisms in Japanese patients with systemic lupus erythematosus: contribution of FCGR2B to genetic susceptibility‏ ‎‡9  1‏
919 ‎‡a  fcgammareceptorpolymorphismsinsystemiclupuserythematosusassociationwithdiseaseandinvivoclearanceofimmunecomplexes‏ ‎‡A  Fcgamma receptor polymorphisms in systemic lupus erythematosus: association with disease and in vivo clearance of immune complexes‏ ‎‡9  1‏
919 ‎‡a  gangliosidespecificiggandigarecruitleukocyteeffectorfunctionsinguillainbarresyndrome‏ ‎‡A  Ganglioside-specific IgG and IgA recruit leukocyte effector functions in Guillain-Barré syndrome‏ ‎‡9  1‏
919 ‎‡a  iviginhibitsclassicalpathwayactivityandantigm1igmmediatedcomplementdepositioninmmn‏ ‎‡A  IVIg inhibits classical pathway activity and anti-GM1 IgM-mediated complement deposition in MMN‏ ‎‡9  1‏
919 ‎‡a  leukocyteandcomplementactivationbygm1specificantibodiesisassociatedwithacutemotoraxonalneuropathyinrabbits‏ ‎‡A  Leukocyte and complement activation by GM1-specific antibodies is associated with acute motor axonal neuropathy in rabbits‏ ‎‡9  1‏
919 ‎‡a  noassociationoffcgammariiafcgammariiiaandfcgammariiibpolymorphismswithms‏ ‎‡A  No association of Fc gamma RIIa, Fc gamma RIIIa and Fc gamma RIIIb polymorphisms with MS.‏ ‎‡9  1‏
919 ‎‡a  pathogenicityofantigangliosideantibodiesintheguillainbarresyndrome‏ ‎‡A  Pathogenicity of anti-ganglioside antibodies in the Guillain-Barré syndrome.‏ ‎‡9  1‏
919 ‎‡a  quantificationofsmnproteininleucocytesfromspinalmuscularatrophypatientseffectsoftreatmentwithvalproicacid‏ ‎‡A  Quantification of SMN protein in leucocytes from spinal muscular atrophy patients: effects of treatment with valproic acid‏ ‎‡9  1‏
919 ‎‡a  relevanceoffcgammareceptorandinterleukin10polymorphismsformeningococcaldisease‏ ‎‡A  Relevance of Fcgamma receptor and interleukin-10 polymorphisms for meningococcal disease‏ ‎‡9  1‏
919 ‎‡a  sccmectypinginmethicillinresistantstaphylococcusaureusstrainsofanimalorigin‏ ‎‡A  SCCmec typing in methicillin-resistant Staphylococcus aureus strains of animal origin.‏ ‎‡9  1‏
919 ‎‡a  severityofguillainbarresyndromeisassociatedwithfcgammareceptor3polymorphisms‏ ‎‡A  Severity of Guillain-Barré syndrome is associated with Fc gamma Receptor III polymorphisms‏ ‎‡9  1‏
919 ‎‡a  streptococcuspneumoniaeinsalivaofdutchprimaryschoolchildren‏ ‎‡A  Streptococcus pneumoniae in saliva of Dutch primary school children‏ ‎‡9  1‏
919 ‎‡a  rhpolymorphismoffcgammareceptoriiaasariskfactorforsystemiclupuserythematosusisindependentofsinglenucleotidepolymorphismsintheinterleukin10genepromoter‏ ‎‡A  The R-H polymorphism of FCgamma receptor IIa as a risk factor for systemic lupus erythematosus is independent of single-nucleotide polymorphisms in the interleukin-10 gene promoter‏ ‎‡9  1‏
919 ‎‡a  transmissionofmethicillinresistantstaphylococcusaureusstrainsbetweendifferentkindsofpigfarms‏ ‎‡A  Transmission of methicillin-resistant Staphylococcus aureus strains between different kinds of pig farms‏ ‎‡9  1‏
946 ‎‡a  b‏ ‎‡9  1‏
996 ‎‡2  DNB|136871380
996 ‎‡2  LC|n 81030742
996 ‎‡2  SUDOC|070151016
996 ‎‡2  BNF|12219784
996 ‎‡2  BNF|12020854
996 ‎‡2  DBC|87097938502824
996 ‎‡2  NKC|jo2017965377
996 ‎‡2  DNB|1106142934
996 ‎‡2  NTA|238722589
996 ‎‡2  ISNI|0000000390748575
996 ‎‡2  NTA|156629682
996 ‎‡2  BIBSYS|4014850
996 ‎‡2  NTA|106518356
996 ‎‡2  ISNI|0000000392167635
996 ‎‡2  ISNI|0000000391384240
996 ‎‡2  DNB|13762283X
996 ‎‡2  NTA|069243638
996 ‎‡2  NTA|06935555X
996 ‎‡2  ISNI|0000000397120019
996 ‎‡2  ISNI|0000000004968474
996 ‎‡2  NTA|327843551
996 ‎‡2  NTA|43883304X
996 ‎‡2  NTA|203403460
996 ‎‡2  LC|n 80074961
996 ‎‡2  ISNI|0000000024638587
996 ‎‡2  NTA|323265235
996 ‎‡2  NTA|067943829
996 ‎‡2  DNB|1215926189
996 ‎‡2  BIBSYS|3121863
996 ‎‡2  DNB|1032680458
996 ‎‡2  DNB|1303262320
996 ‎‡2  ISNI|0000000046729834
996 ‎‡2  LC|no2024032373
996 ‎‡2  ISNI|0000000388528901
996 ‎‡2  NTA|085848697
996 ‎‡2  ISNI|0000000053778802
996 ‎‡2  BNF|17985533
996 ‎‡2  LC|n 83158330
996 ‎‡2  NYNYRILM|42029
996 ‎‡2  NTA|070670250
996 ‎‡2  ISNI|0000000390272730
996 ‎‡2  NTA|369882881
996 ‎‡2  BNF|14509593
996 ‎‡2  NTA|298808560
996 ‎‡2  NUKAT|n 2020075066
996 ‎‡2  BNF|18168101
996 ‎‡2  ISNI|0000000395372554
996 ‎‡2  NKC|xx0196178
996 ‎‡2  NTA|391143921
996 ‎‡2  LC|no2016081264
996 ‎‡2  NTA|074782819
996 ‎‡2  J9U|987007342596905171
996 ‎‡2  LC|n 77019472
996 ‎‡2  ISNI|0000000131672094
996 ‎‡2  NTA|228129524
996 ‎‡2  NTA|41193631X
996 ‎‡2  LC|n 2002151175
996 ‎‡2  DNB|173965776
996 ‎‡2  ISNI|0000000394484685
996 ‎‡2  ISNI|0000000121326964
996 ‎‡2  NTA|070185336
996 ‎‡2  RERO|A023097276
996 ‎‡2  NTA|430257325
996 ‎‡2  NTA|383785219
996 ‎‡2  JPG|500381765
996 ‎‡2  DNB|173093914
996 ‎‡2  NTA|313899002
996 ‎‡2  NTA|395476143
996 ‎‡2  ISNI|0000000061271200
996 ‎‡2  J9U|987012160368305171
996 ‎‡2  ISNI|0000000072523434
996 ‎‡2  NTA|074150871
996 ‎‡2  DNB|1027511007
996 ‎‡2  JPG|500020839
996 ‎‡2  DNB|1022866850
996 ‎‡2  NTA|073232920
996 ‎‡2  NTA|262213729
996 ‎‡2  DNB|135319609
996 ‎‡2  ISNI|000000039343693X
996 ‎‡2  ISNI|0000000402773314
996 ‎‡2  NTA|292373139
996 ‎‡2  DNB|1055209077
996 ‎‡2  ISNI|0000000394574031
996 ‎‡2  SUDOC|028356373
996 ‎‡2  NTA|241602521
996 ‎‡2  LC|nr2002029399
996 ‎‡2  NTA|434080470
996 ‎‡2  NTA|068778503
996 ‎‡2  RERO|A003420034
996 ‎‡2  NTA|10091148X
996 ‎‡2  ISNI|0000000073098388
996 ‎‡2  J9U|987007434736105171
996 ‎‡2  LC|no2023123464
996 ‎‡2  ISNI|0000000029562753
996 ‎‡2  NTA|155363891
996 ‎‡2  DNB|121576760
996 ‎‡2  NKC|mub20241237885
996 ‎‡2  BNF|16679711
996 ‎‡2  ISNI|0000000397073881
996 ‎‡2  ISNI|0000000019623858
996 ‎‡2  ISNI|0000000392824383
996 ‎‡2  ISNI|000000039717923X
996 ‎‡2  NTA|32585467X
996 ‎‡2  SUDOC|175207054
996 ‎‡2  CAOONL|ncf11451519
996 ‎‡2  ISNI|000000051121436X
996 ‎‡2  NTA|329715445
996 ‎‡2  ISNI|0000000390100496
996 ‎‡2  DNB|1019187042
996 ‎‡2  NTA|079463312
996 ‎‡2  NTA|074530984
996 ‎‡2  DNB|131348892
996 ‎‡2  ISNI|0000000509879039
996 ‎‡2  SUDOC|233052488
996 ‎‡2  ISNI|0000000028354450
996 ‎‡2  NTA|315590807
996 ‎‡2  DNB|1203839014
996 ‎‡2  ISNI|0000000393918517
996 ‎‡2  NTA|341692948
996 ‎‡2  NTA|400227770
996 ‎‡2  DNB|133589676
996 ‎‡2  BAV|495_153121
996 ‎‡2  J9U|987009747798105171
996 ‎‡2  LC|n 2002017029
996 ‎‡2  SELIBR|260849
996 ‎‡2  SUDOC|114900345
996 ‎‡2  NTA|068916477
996 ‎‡2  NTA|406502501
996 ‎‡2  LC|no2023006622
996 ‎‡2  NTA|167680153
996 ‎‡2  ISNI|0000000387196132
996 ‎‡2  DNB|134868307
996 ‎‡2  RERO|A026727952
996 ‎‡2  NTA|321597591
996 ‎‡2  DNB|1309783438
996 ‎‡2  NTA|074954911
996 ‎‡2  BIBSYS|2064168
996 ‎‡2  NTA|380684160
996 ‎‡2  LC|no2022146231
996 ‎‡2  BNF|15576290
996 ‎‡2  NII|DA13155123
996 ‎‡2  NTA|21624840X
996 ‎‡2  SUDOC|030868491
996 ‎‡2  DNB|1210177854
996 ‎‡2  ISNI|0000000395979735
996 ‎‡2  BLBNB|000525360
996 ‎‡2  NTA|426267575
996 ‎‡2  BNF|11180444
996 ‎‡2  RERO|A012323912
996 ‎‡2  ISNI|0000000079397936
996 ‎‡2  ISNI|0000000394752475
996 ‎‡2  NTA|438284801
996 ‎‡2  NTA|304810908
996 ‎‡2  ISNI|0000000396927582
996 ‎‡2  DBC|87097968452074
996 ‎‡2  DNB|174102755
996 ‎‡2  NTA|074031449
996 ‎‡2  NTA|411307452
996 ‎‡2  ISNI|0000000388027402
996 ‎‡2  DNB|1319605281
996 ‎‡2  DNB|1126266396
996 ‎‡2  NTA|071274944
996 ‎‡2  DNB|1145427782
996 ‎‡2  NTA|134964640
996 ‎‡2  ISNI|0000000397087298
996 ‎‡2  DNB|133368904
996 ‎‡2  ISNI|0000000071018073
996 ‎‡2  DNB|141306653
996 ‎‡2  RERO|A013777940
996 ‎‡2  ISNI|0000000131863165
996 ‎‡2  ISNI|0000000390521143
996 ‎‡2  LNB|LNC10-000108789
996 ‎‡2  DNB|1020752998
996 ‎‡2  ISNI|0000000366966839
996 ‎‡2  ISNI|0000000023264499
996 ‎‡2  DNB|1078454264
996 ‎‡2  NII|DA18800608
996 ‎‡2  SUDOC|146843371
996 ‎‡2  DNB|1015131514
996 ‎‡2  ISNI|0000000388886901
996 ‎‡2  NTA|071467726
996 ‎‡2  ISNI|0000000396629630
996 ‎‡2  ISNI|0000000057606645
996 ‎‡2  NTA|157343979
996 ‎‡2  ISNI|0000000000172663
996 ‎‡2  NTA|387127801
996 ‎‡2  NTA|143403583
996 ‎‡2  DNB|143502255
996 ‎‡2  LC|n 94020098
996 ‎‡2  DNB|1034914154
996 ‎‡2  RERO|A023648395
996 ‎‡2  ISNI|0000000391361647
996 ‎‡2  NTA|072083018
996 ‎‡2  NTA|311460577
996 ‎‡2  J9U|987007273780105171
996 ‎‡2  NUKAT|n 02724644
996 ‎‡2  ISNI|000000039388883X
996 ‎‡2  DNB|1131201477
996 ‎‡2  DNB|1306323223
996 ‎‡2  NTA|391929275
996 ‎‡2  ISNI|0000000393082254
996 ‎‡2  LC|n 92045985
996 ‎‡2  RERO|A009273980
996 ‎‡2  LIH|LNB:BZ_w__z_;=C_d_
996 ‎‡2  ISNI|0000000022040602
996 ‎‡2  ISNI|0000000398890437
996 ‎‡2  PLWABN|9810704144605606
996 ‎‡2  NTA|082530939
996 ‎‡2  CAOONL|ncf11347779
996 ‎‡2  NTA|306309572
996 ‎‡2  ISNI|0000000389066884
996 ‎‡2  NTA|127707603
996 ‎‡2  ISNI|0000000388791654
996 ‎‡2  NTA|156842343
996 ‎‡2  NUKAT|n 2010113404
996 ‎‡2  NKC|js20221139893
996 ‎‡2  ISNI|0000000393713482
996 ‎‡2  RERO|A003420026
996 ‎‡2  SUDOC|231818394
996 ‎‡2  LC|nb2012003439
996 ‎‡2  NTA|421351039
996 ‎‡2  NTA|310871646
996 ‎‡2  ISNI|0000000395317029
996 ‎‡2  ISNI|0000000395672469
996 ‎‡2  ISNI|0000000505496807
996 ‎‡2  NTA|154645222
996 ‎‡2  SELIBR|313718
996 ‎‡2  ISNI|0000000073105998
996 ‎‡2  DNB|1077044828
997 ‎‡a  0 0 lived 0 0‏ ‎‡9  1‏